Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Rationale Emphysema progression is heterogeneous. Predicting temporal changes in lung density and detecting rapid progressors may facilitate selection of individuals for targeted therapies. Objective To test whether computed tomography (CT) radiomics can be used to predict changes in lung density and detect rapid progressors. Methods We extracted radiomics features from inspiratory chest CT in 4,575 subjects with and without airflow obstruction at enrollment, who completed a follow-up visit at approximately 5 years. We quantified emphysema using adjusted lung density (ALD) and estimated emphysema progression as the annualized change in ALD (∆ALD/year) between visits. We categorized participants into rapid progressors (>1% ∆ALD/year) and stable disease (≤1% ∆ALD/year). A gradient boosting model was used (1) to predict ALD at 5-years and (2) to identify rapid progressors. Four models using demographics (base clinical model); CT density; radiomics; and combined features (clinical, radiomics, and CT density) were evaluated and tested. Results There were 1,773 (38.8%) rapid progressors. For predicting ALD at 5-years in the 20% held-out data, the base model explained 31% of the variance (adjusted R2 = 0.31) whereas R2 was 0.74 for the CT density model, 0.66 for the radiomics-only model, and 0.77 for the combined features model. For detecting rapid progressors, the base model (AUC = 0.57, 95%CI 0.53-0.61) was outperformed by the radiomics-only model (AUC = 0.73, 95%CI 0.69-0.76, ∆ =0.0003, p < 0.001) and the combined model (AUC = 0.74, 95%CI 0.71-0.77, ∆ = 0.0003, p < 0.001). Conclusions Parenchymal and airway radiomics features derived from inspiratory scans can be used to predict temporal changes in lung density and help identify rapid progressors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708762PMC
http://dx.doi.org/10.1513/AnnalsATS.202401-009OCDOI Listing

Publication Analysis

Top Keywords

rapid progressors
28
lung density
20
radiomics features
12
emphysema progression
12
changes lung
12
model auc
12
model
9
density
8
temporal changes
8
detecting rapid
8

Similar Publications

Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression.

BMC Nephrol

August 2025

Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Background: Previous cross-sectional transcriptomics studies on diabetic kidney disease (DKD) kidney tissue have shown correlations between gene expression and both disease status and kidney function at the time of biopsy; however, longitudinal data are scarce.

Methods: We utilized clinical follow-up data up to five years post-biopsy, linking the transcriptomes of diagnostic kidney biopsies to progression rates and outcomes in 19 patients with DKD. Patients were stratified into “rapid progressors” and “non-rapid progressors” based on clinical parameters (eGFR slope, CKD stage advancement, degree of albuminuria, composite outcome of kidney failure or 40% eGFR decline).

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is still a heterogeneous neurodegenerative disorder that can be identified clinically and biologically, without a strong set of biomarkers that can adequately measure its fast rate of progression and molecular heterogeneity. In this review, we intend to consolidate the most relevant and timely advances in ALS biomarker discovery, in order to begin to bring molecular, imaging, genetic, and digital areas together for potential integration into a precision medicine approach to ALS. Our goal is to begin to display how several biomarkers in development (e.

View Article and Find Full Text PDF

Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common monogenic kidney disease, leading to progressive renal function loss. Systemic arterial hypertension is a frequent early onset extrarenal manifestation with an incompletely understood pathogenesis. Therefore, this study investigated cardiovascular autonomic control at rest and during physiological sympathetic stimulation, along with humoral and urinary molecules involved in blood pressure (BP) regulation, in young ADPKD patients before hypertension and renal dysfunction onset.

View Article and Find Full Text PDF

Objective: We aimed to identify unique disease trajectories within rheumatoid arthritis-associated interstitial lung disease (RA-ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes.

Methods: We performed a cohort study of RA-ILD within the Veterans Health Administration from 1999-2021. RA-ILD patients were identified with validated algorithms.

View Article and Find Full Text PDF

Rapid Progression of Right Ventricular Deterioration and Timing of Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.

Heart Lung Circ

September 2025

The Blalock-Taussig-Thomas Pediatric and Congenital Heart Center, Department of Pediatrics, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Background: We aimed to identify a progressive phenotype in repaired tetralogy of Fallot (rTOF), characterised by accelerated changes in right ventricular (RV) parameters on cardiac magnetic resonance (CMR) and assess its association with an accelerated course to pulmonary valve replacement (PVR).

Method: This was a retrospective study of patients with rTOF who had two or more CMRs (2005-2022). Clinical variables and CMR data were collected, and annualised changes in CMR data were calculated.

View Article and Find Full Text PDF